{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T01:49:37Z","timestamp":1778809777213,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["17JCZDJC35300,15JCZDJC35400 and JCYBJC27200"],"award-info":[{"award-number":["17JCZDJC35300,15JCZDJC35400 and JCYBJC27200"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tianjin Municipal Natural Science Foundation","award":["grant 17JCYBJC26000"],"award-info":[{"award-number":["grant 17JCYBJC26000"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12885-019-5847-2","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T14:03:15Z","timestamp":1561471395000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis"],"prefix":"10.1186","volume":"19","author":[{"given":"Jian","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi Miao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi Liang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong Tan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan Jie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"3","key":"5847_CR1","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/00042307-200105000-00010","volume":"11","author":"G Mobilio","year":"2001","unstructured":"Mobilio G, Ficarra V. Genital treatment of penile carcinoma. Curr Opin Urol. 2001;11(3):299\u2013304.","journal-title":"Curr Opin Urol"},{"key":"5847_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2009\/415062","volume":"2009","author":"A. Rando Sous","year":"2009","unstructured":"Rando Sous A, P\u00e9rez-Utrilla P\u00e9rez M, Aguilera Baz\u00e1n A, Tabernero Gomez A, Cisneros Ledo J, De la Pe\u00f1a Barthel J. A review of penile cancer. Adv Urol. 2009:415062. https:\/\/doi.org\/10.1155\/2009\/415062 .","journal-title":"Advances in Urology"},{"issue":"6","key":"5847_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","volume":"57","author":"Pizzocaro, G., Algaba, F., Horenblas, S., Solsona, E., Tana, S., Van Der Poel, H., . . . European Association of Urology Guidelines Group on Penile, Cancer","year":"2010","unstructured":"Pizzocaro, G., Algaba, F., Horenblas, S., Solsona, E., Tana, S., Van Der Poel, H., . . . European Association of Urology Guidelines Group on Penile, Cancer. EAU penile cancer guidelines 2009. Eur Urol. 2010;57(6):1002\u201312. https:\/\/doi.org\/10.1016\/j.eururo.2010.01.039 .","journal-title":"Eur Urol"},{"issue":"10","key":"5847_CR4","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1038\/bjc.2013.620","volume":"109","author":"S Nicholson","year":"2013","unstructured":"Nicholson, S., Hall, E., Harland, S. J., Chester, J. D., Pickering, L., Barber, J., . . . Bahl, A. (2013). Phase II trial of docetaxel, cisplatin and 5FU chemotherapy in locally advanced and metastatic penis cancer (CRUK\/09\/001). Br J Cancer, 109(10), 2554\u20132559. doi: https:\/\/doi.org\/10.1038\/bjc.2013.620 .","journal-title":"Br J Cancer"},{"issue":"9","key":"5847_CR5","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1111\/j.1464-410X.2011.10647.x","volume":"108","author":"S Deem","year":"2011","unstructured":"Deem S, Keane T, Bhavsar R, El-Zawahary A, Savage S. Contemporary diagnosis and management of squamous cell carcinoma (SCC) of the penis. BJU Int. 2011;108(9):1378\u201392. https:\/\/doi.org\/10.1111\/j.1464-410X.2011.10647.x .","journal-title":"BJU Int"},{"issue":"2","key":"5847_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/01.ju.0000062829.43654.5e","volume":"170","author":"DJ Culkin","year":"2003","unstructured":"Culkin DJ, Beer TM. Advanced penile carcinoma. J Urol. 2003;170(2 Pt 1):359\u201365. https:\/\/doi.org\/10.1097\/01.ju.0000062829.43654.5e .","journal-title":"J Urol"},{"issue":"6","key":"5847_CR7","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0022-5347(05)68815-5","volume":"161","author":"GP Haas","year":"1999","unstructured":"Haas, G. P., Blumenstein, B. A., Gagliano, R. G., Russell, C. A., Rivkin, S. E., Culkin, D. J., . . . Crawford, E. D. (1999). Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a southwest oncology group study. J Urol, 161(6), 1823\u20131825.","journal-title":"J Urol"},{"issue":"17","key":"5847_CR8","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1056\/NEJMoa070956","volume":"357","author":"MR Posner","year":"2007","unstructured":"Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., . . . Group, T. A. X. Study. (2007). Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med, 357(17), 1705\u20131715. doi: https:\/\/doi.org\/10.1056\/NEJMoa070956 .","journal-title":"N Engl J Med"},{"issue":"17","key":"5847_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa071028","volume":"357","author":"Vermorken, J. B., Remenar, E., van Herpen, C., Gorlia, T., Mesia, R., Degardin, M., . . . Group, Eortc Tax Study","year":"2007","unstructured":"Vermorken, J. B., Remenar, E., van Herpen, C., Gorlia, T., Mesia, R., Degardin, M., . . . Group, Eortc Tax Study. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa071028 .","journal-title":"N Engl J Med"},{"issue":"1","key":"5847_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.clgc.2014.06.005","volume":"13","author":"RS Djajadiningrat","year":"2015","unstructured":"Djajadiningrat RS, Bergman AM, et al. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin Genitourin Cancer. 2015;13(1):44\u20139. https:\/\/doi.org\/10.1016\/j.clgc.2014.06.005 .","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"5847_CR11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.juro.2006.11.038","volume":"177","author":"C Bermejo","year":"2007","unstructured":"Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol. 2007;177(4):1335\u20138. https:\/\/doi.org\/10.1016\/j.juro.2006.11.038 .","journal-title":"J Urol"},{"issue":"24","key":"5847_CR12","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1200\/JCO.2010.29.5477","volume":"28","author":"LC Pagliaro","year":"2010","unstructured":"Pagliaro, L. C., Williams, D. L., Daliani, D., Williams, M. B., Osai, W., Kincaid, M., . . . Pettaway, C. A. (2010). Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol, 28(24), 3851\u20133857. doi: https:\/\/doi.org\/10.1200\/JCO.2010.29.5477 .","journal-title":"J Clin Oncol"},{"issue":"2","key":"5847_CR13","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00000658-192102000-00001","volume":"73","author":"AC Broders","year":"1921","unstructured":"Broders AC. Squamous-cell Epithelioma of the skin: a study of 256 cases. Ann Surg. 1921;73(2):141\u201360.","journal-title":"Ann Surg"},{"issue":"2","key":"5847_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., . . . Verweij, J. (2009). New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45(2), 228\u2013247. doi: https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026 .","journal-title":"Eur J Cancer"},{"issue":"2","key":"5847_CR15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0094-0143(21)00389-X","volume":"19","author":"RM Cabanas","year":"1992","unstructured":"Cabanas RM. Anatomy and biopsy of sentinel lymph nodes. Urol Clin North Am. 1992;19(2):267\u201376.","journal-title":"Urol Clin North Am"},{"issue":"2","key":"5847_CR16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0094-0143(21)00387-6","volume":"19","author":"JK Burgers","year":"1992","unstructured":"Burgers JK, Badalament RA, Drago JR. Penile cancer. Clinical presentation, diagnosis, and staging. Urol Clin North Am. 1992;19(2):247\u201356.","journal-title":"Urol Clin North Am"},{"issue":"1","key":"5847_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/bju.12946","volume":"117","author":"RJ Dickstein","year":"2016","unstructured":"Dickstein RJ, Munsell MF, Pagliaro LC, Pettaway CA. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy. BJU Int. 2016;117(1):118\u201325. https:\/\/doi.org\/10.1111\/bju.12946 .","journal-title":"BJU Int"},{"issue":"6","key":"5847_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jso.20980","volume":"97","author":"AA Ornellas","year":"2008","unstructured":"Ornellas AA, Kinchin EW, Nobrega BL, Wisnescky A, Koifman N, Quirino R. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol. 2008;97(6):487\u201395. https:\/\/doi.org\/10.1002\/jso.20980 .","journal-title":"J Surg Oncol"},{"issue":"4","key":"5847_CR19","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.juro.2010.06.016","volume":"184","author":"NM Graafland","year":"2010","unstructured":"Graafland NM, van Boven HH, van Werkhoven E, Moonen LM, Horenblas S. Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol. 2010;184(4):1347\u201353. https:\/\/doi.org\/10.1016\/j.juro.2010.06.016 .","journal-title":"J Urol"},{"issue":"2","key":"5847_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jso.20414","volume":"93","author":"D Pandey","year":"2006","unstructured":"Pandey D, Mahajan V, Kannan RR. Prognostic factors in node-positive carcinoma of the penis. J Surg Oncol. 2006;93(2):133\u20138. https:\/\/doi.org\/10.1002\/jso.20414 .","journal-title":"J Surg Oncol"},{"issue":"5","key":"5847_CR21","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.urolonc.2010.09.015","volume":"30","author":"HM Rosevear","year":"2012","unstructured":"Rosevear HM, Williams H, Collins M, Lightfoot AJ, Coleman T, Brown JA. Utility of (1)(8) F-FDG PET\/CT in identifying penile squamous cell carcinoma metastatic lymph nodes. Urol Oncol. 2012;30(5):723\u20136. https:\/\/doi.org\/10.1016\/j.urolonc.2010.09.015 .","journal-title":"Urol Oncol"},{"issue":"6","key":"5847_CR22","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/S0022-5347(17)39130-9","volume":"142","author":"EE Fraley","year":"1989","unstructured":"Fraley EE, Zhang G, Manivel C, Niehans GA. The role of ilioinguinal lymphadenectomy and significance of histological differentiation in treatment of carcinoma of the penis. J Urol. 1989;142(6):1478\u201382.","journal-title":"J Urol"},{"issue":"5","key":"5847_CR23","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1464-410X.1993.tb16273.x","volume":"72","author":"R Ravi","year":"1993","unstructured":"Ravi R. Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol. 1993;72(5 Pt 2):817\u20139.","journal-title":"Br J Urol"},{"issue":"1","key":"5847_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000176016","volume":"82","author":"C Protzel","year":"2009","unstructured":"Protzel C, Hakenberg OW. Chemotherapy in patients with penile carcinoma. Urol Int. 2009;82(1):1\u20137. https:\/\/doi.org\/10.1159\/000176016 .","journal-title":"Urol Int"},{"issue":"5","key":"5847_CR25","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/S0022-5347(17)38069-2","volume":"146","author":"FH Dexeus","year":"1991","unstructured":"Dexeus FH, Logothetis CJ, Sella A, Amato R, Kilbourn R, Fitz K, Striegel A. Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol. 1991;146(5):1284\u20137.","journal-title":"J Urol"},{"issue":"5","key":"5847_CR26","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/S0022-5347(01)62402-9","volume":"160","author":"DA Corral","year":"1998","unstructured":"Corral DA, Sella A, Pettaway CA, Amato RJ, Jones DM, Ellerhorst J. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotrexate, cisplatin and bleomycin. J Urol. 1998;160(5):1770\u20134.","journal-title":"J Urol"},{"issue":"6","key":"5847_CR27","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/j.1464-410X.2006.06496.x","volume":"98","author":"OW Hakenberg","year":"2006","unstructured":"Hakenberg OW, Nippgen JB, Froehner M, Zastrow S, Wirth MP. Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int. 2006;98(6):1225\u20137. https:\/\/doi.org\/10.1111\/j.1464-410X.2006.06496.x .","journal-title":"BJU Int"},{"key":"5847_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-8722-7-1","volume":"7","author":"LR Molife","year":"2014","unstructured":"Molife, L. R., Yan, L., Vitfell-Rasmussen, J., Zernhelt, A. M., Sullivan, D. M., Cassier, P. A., . . . Minton, S. (2014). Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin\/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors. J Hematol Oncol, 7, 1. doi: https:\/\/doi.org\/10.1186\/1756-8722-7-1 .","journal-title":"J Hematol Oncol"},{"issue":"6","key":"5847_CR29","doi-asserted-by":"publisher","first-page":"e0129168","DOI":"10.1371\/journal.pone.0129168","volume":"10","author":"M St George","year":"2015","unstructured":"St George, M., Ayoub, A. T., Banerjee, A., Churchill, C. D., Winter, P., Klobukowski, M., . . . Damaraju, S. (2015). Designing and testing of novel Taxanes to probe the highly complex mechanisms by which Taxanes bind to microtubules and cause cytotoxicity to Cancer cells. PLoS One, 10(6), e0129168. doi: https:\/\/doi.org\/10.1371\/journal.pone.0129168 .","journal-title":"PLoS One"},{"issue":"2","key":"5847_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00280-015-2893-6","volume":"77","author":"M Joerger","year":"2016","unstructured":"Joerger M. Treatment regimens of classical and newer taxanes. Cancer Chemother Pharmacol. 2016;77(2):221\u201333. https:\/\/doi.org\/10.1007\/s00280-015-2893-6 .","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"5847_CR31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.ctrv.2015.10.010","volume":"41","author":"CN Frederiks","year":"2015","unstructured":"Frederiks CN, Lam SW, Guchelaar HJ, Boven E. Genetic polymorphisms and paclitaxel- or docetaxel-induced toxicities: a systematic review. Cancer Treat Rev. 2015;41(10):935\u201350. https:\/\/doi.org\/10.1016\/j.ctrv.2015.10.010 .","journal-title":"Cancer Treat Rev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-019-5847-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-019-5847-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T21:14:32Z","timestamp":1663794872000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-019-5847-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5847"],"URL":"https:\/\/doi.org\/10.1186\/s12885-019-5847-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"20 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by an independent ethical committee\/institutional review board of the Second Hospital of Tianjin Medical University, Tianjin, China. Written informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"625"}}